Sensorion reels in 4 mln euros

By Iris Dorbian — 1 year ago

Sensorion SA, a French biotech firm that focuses on treating inner ear diseases, has received up to four million euros in funding. The backers were Innobio and Inserm Transfert Initiative.

Continue

Gentical Raises $23.7M From Wellington, EdRIP, InnoBio, Others

By Mark Boslet — 3 years ago

Wellington Partners said it is the lead investor in a $23.7 million Series C financing round for Genticel which was closed this week. Wellington Partners committed about $5 million and the remaining came from existing shareholders, including EdRIP, IDInvest, InnoBio, IRDI and Amundi. The funds will be used primarily to finance a phase II program for the Toulouse, France-based HPV- vaccine developer’s lead product ProCervix.

Continue

Wellington Leads Genticel Financing

By Angela Sormani — 3 years ago

Wellington Partners has led a 18.2 million euros series C financing round at Toulouse/France-based therapeutic HPV- vaccine developer Genticel. Wellington Partners committed 4 million euros to this financing. The remaining 14.2 million euros were provided by the existing shareholders including EdRIP, IDInvest, InnoBio, IRDI and Amundi.

Continue

InnoBio Gets Backing

By Angela Sormani — 3 years ago

InnoBio, a biotech fund managed by CDC Entreprises, and Sofinnova Partners have announced a joint investment in MedDay for 8 million euros ($10.5 million). Created in 2011 by Dr Frédéric Sedel and Dr Guillaume Brion, MedDay is specialised in the treatment of neuro-metabolic diseases.

Continue

Poxel Appoints Khoso Baluch to Board

By Angela Sormani — 3 years ago

Biopharma startup Poxel has appointed Khoso Baluch to its board of directors. Baluch will serve as an independent director. He is senior vice president & president European region at UCB, the global biopharmaceutical company. Poxel is backed by Edmond de Rothschild Investment Partners, InnoBio and Omnes Capital.

Continue